Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01020023 | CE(17:1) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | - | pmol/sample |
| LMST01020023 | CE(17:1) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | - | pmol/sample |
| LMST01020023 | CE(17:1) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 1.57 | pmol/sample |
| LMST01020023 | CE(17:1) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 1.26 | pmol/sample |
| LMST01020023 | CE(17:1) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 1.04 | pmol/sample |
| LMST01020023 | CE(17:1) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 1.15 | pmol/sample |
| LMST01020023 | CE(17:1) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 1.48 | pmol/sample |
| LMST01020023 | CE(17:1) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | - | pmol/sample |
| LMST01020023 | CE(17:1) | C | 0.0 | BCD100322A01 | 3.58 | pmol/sample |
| LMST01020023 | CE(17:1) | C | 0.5 | BCD100322A03 | 5.49 | pmol/sample |
| LMST01020023 | CE(17:1) | C | 1.0 | BCD100322A07 | 4.45 | pmol/sample |
| LMST01020023 | CE(17:1) | C | 2.0 | BCD100322A11 | 3.67 | pmol/sample |
| LMST01020023 | CE(17:1) | C | 4.0 | BCD100322A15 | 2.57 | pmol/sample |
| LMST01020023 | CE(17:1) | C | 8.0 | BCD100322A19 | 4.63 | pmol/sample |
| LMST01020023 | CE(17:1) | C | 12.0 | BCD100322A23 | 4.53 | pmol/sample |
| LMST01020023 | CE(17:1) | C | 24.0 | BCD100322A27 | 2.31 | pmol/sample |
| LMST01020023 | CE(17:1) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 1.33 | pmol/sample |
| LMST01020023 | CE(17:1) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 2.42 | pmol/sample |
| LMST01020023 | CE(17:1) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 1.53 | pmol/sample |
| LMST01020023 | CE(17:1) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 3.05 | pmol/sample |
| LMST01020023 | CE(17:1) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 3.69 | pmol/sample |
| LMST01020023 | CE(17:1) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 2.18 | pmol/sample |
| LMST01020023 | CE(17:1) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 4.13 | pmol/sample |
| LMST01020023 | CE(17:1) | 25OH-Chol | 0.5 | BCD100322A04 | 6.62 | pmol/sample |
| LMST01020023 | CE(17:1) | 25OH-Chol | 1.0 | BCD100322A08 | 4.53 | pmol/sample |
| LMST01020023 | CE(17:1) | 25OH-Chol | 2.0 | BCD100322A12 | 3.99 | pmol/sample |
| LMST01020023 | CE(17:1) | 25OH-Chol | 4.0 | BCD100322A16 | 4.16 | pmol/sample |
| LMST01020023 | CE(17:1) | 25OH-Chol | 8.0 | BCD100322A20 | 5.6 | pmol/sample |
| LMST01020023 | CE(17:1) | 25OH-Chol | 12.0 | BCD100322A24 | 4.21 | pmol/sample |
| LMST01020023 | CE(17:1) | 25OH-Chol | 24.0 | BCD100322A28 | 3.27 | pmol/sample |